Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoyuki Nishikawa

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cancer Science|September 26, 2017
Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cellsSimin Li, Tomoyuki Nishikawa, Yasufumi Kaneda
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2014
Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in miceTomoyuki Nishikawa, Li Yu Tung, Yasufumi Kaneda
Oncotarget|May 1, 2017
Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growthChe-Hsin Lee, Tomoyuki Nishikawa, Yasufumi Kaneda
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2015
An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective ApoptosisLi-Wen Liu, Tomoyuki Nishikawa, Yasufumi Kaneda
Scientific Reports|April 28, 2016
Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet AggregationYu-Tung Li, Tomoyuki Nishikawa, Yasufumi Kaneda
Cancer Gene Therapy|August 7, 2019
Cancer immunotherapy using the Fusion gene of Sendai virusJiayu A Tai, Chin Yang Chang, Tomoyuki Nishikawa, et al.
Oncotarget|June 4, 2016
Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunityChin Yang Chang, Jiayu A Tai, Sumin Li, et al.
Molecular Therapy Oncolytics|February 12, 2021
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapyYi Chun Pan, Tomoyuki Nishikawa, Chin Yang Chang, et al.
Vaccines|July 27, 2024
Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet InjectorJiayu A Tai, Tomoyuki Nishikawa, Hiroki Hayashi, et al.
FEBS Open Bio|January 18, 2023
Enhancement of polyethylene glycol-cell fusion efficiency by novel application of transient pressure using a jet injectorChin Yang Chang, Jiayu A Tai, Yuko Sakaguchi, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cancer Science|September 26, 2017
Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cellsSimin Li, Tomoyuki Nishikawa, Yasufumi Kaneda
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2014
Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in miceTomoyuki Nishikawa, Li Yu Tung, Yasufumi Kaneda
Oncotarget|May 1, 2017
Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growthChe-Hsin Lee, Tomoyuki Nishikawa, Yasufumi Kaneda
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2015
An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective ApoptosisLi-Wen Liu, Tomoyuki Nishikawa, Yasufumi Kaneda
Scientific Reports|April 28, 2016
Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet AggregationYu-Tung Li, Tomoyuki Nishikawa, Yasufumi Kaneda
Cancer Gene Therapy|August 7, 2019
Cancer immunotherapy using the Fusion gene of Sendai virusJiayu A Tai, Chin Yang Chang, Tomoyuki Nishikawa, et al.
Oncotarget|June 4, 2016
Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunityChin Yang Chang, Jiayu A Tai, Sumin Li, et al.
Molecular Therapy Oncolytics|February 12, 2021
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapyYi Chun Pan, Tomoyuki Nishikawa, Chin Yang Chang, et al.
Vaccines|July 27, 2024
Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet InjectorJiayu A Tai, Tomoyuki Nishikawa, Hiroki Hayashi, et al.
FEBS Open Bio|January 18, 2023
Enhancement of polyethylene glycol-cell fusion efficiency by novel application of transient pressure using a jet injectorChin Yang Chang, Jiayu A Tai, Yuko Sakaguchi, et al.
Pageof 3